Publications

Download publications: 
Expand all
2019
  • Kreuter, R., Wankell, M., Ahlenstiel, G., Hebbard, L. (2019). The role of obesity in inflammatory bowel disease. Biochimica et Biophysica Acta-Molecular Basis of Disease. 1865 (1) , 63-72. [More Information]

2018
  • van der Poorten, D., McLeod, D., Ahlenstiel, G., Read, S., Limaye, S., Lin, M., Swaminathan, S., Riminton, S., Kwok, A., Santhakumar, C., et al (2018). Gastric Cancer Screening in Common Variable Immunodeficiency. Journal of Clinical Immunology. 38 (7) , 768-777. [More Information]
  • Read, S., Parnell, G., Booth, D., Douglas, M., George, J., Ahlenstiel, G. (2018). The antiviral role of zinc and metallothioneins in hepatitis C infection. Journal of Viral Hepatitis. 25 (5) , 491-501. [More Information]
  • Read, S., Parnell, G., Booth, D., Douglas, M., George, J., Ahlenstiel, G. (2018). The antiviral role of zinc and metallothioneins in hepatitis C infection. Journal of Viral Hepatitis. 25 (5) , 491-501. [More Information]

2017
  • Obeid, S., Wankell, M., Charrez, B., Sternberg, J., Kreuter, R., Esmaili, S., Ramezani-Moghadam, M., Devine, C., Read, S., Bhathal, P., Ahlenstiel, G., Qiao, L., George, J., Hebbard, L., et al (2017). Adiponectin confers protection from acute colitis and restricts a B cell immune response. Journal of Biological Chemistry. 292 (16) , 6569-6582. [More Information]
  • Obeid, S., Wankell, M., Charrez, B., Sternberg, J., Kreuter, R., Esmaili, S., Ramezani-Moghadam, M., Devine, C., Read, S., Bhathal, P., Ahlenstiel, G., Qiao, L., George, J., Hebbard, L., et al (2017). Adiponectin confers protection from acute colitis and restricts a B cell immune response. Journal of Biological Chemistry. 292 (16) , 6569-6582. [More Information]
  • Ahlenstiel, G. (2017). Commentary. Gastroenterology Research Review. 40 , 1-4.

    Show 12 more
  • Ahlenstiel, G. (2017). Commentary. Gastroenterology Research Review. 42 , 1-1.
  • Ahlenstiel, G. (2017). Commentary. Gastroenterology Research Review. 44 , 1-1.
  • Ahlenstiel, G. (2017). Commentary. Gastroenterology Research Review. 41 , 1-1.
  • Ahlenstiel, G. (2017). Commentary. Gastroenterology Research Review. 43 , 1-1.
  • Mah, X., Gupta, V., Loch, S., Ahlenstiel, G., van der Poorten, D. (2017). Compounded Levofloxacin Triple Therapy is Safe and Effective for Refractory Helicobacter pylori. International Journal of Pharmaceutical Compounding. 21 (3) , 248-251.
  • Klein, A., Ahlenstiel, G., Tate, D., Burgess, N., Richardson, A., Pang, T., Byth, K., Bourke, M. (2017). Endoscopic resection of large duodenal and papillary lateral spreading lesions is clinically and economically advantageous compared with surgery. Endoscopy. 49 (7) , 659-667. [More Information]
  • Read, S., O'Connor, K., Suppiah, V., Ahlenstiel, C., Obeid, S., Cook, K., Cunningham, A., Douglas, M., Hogg, P., Booth, D., George, J., Ahlenstiel, G. (2017). Zinc is a potent and specific inhibitor of IFN-(lambda)3 signaling. Nature Communications. 8 , 1-15. [More Information]
  • Read, S., O'Connor, K., Suppiah, V., Ahlenstiel, C., Obeid, S., Cook, K., Cunningham, A., Douglas, M., Hogg, P., Booth, D., George, J., Ahlenstiel, G. (2017). Zinc is a potent and specific inhibitor of IFN-(lambda)3 signaling. Nature Communications. 8 , 1-15. [More Information]
  • Read, S., O'Connor, K., Suppiah, V., Ahlenstiel, C., Obeid, S., Cook, K., Cunningham, A., Douglas, M., Hogg, P., Booth, D., George, J., Ahlenstiel, G. (2017). Zinc is a potent and specific inhibitor of IFN-/\3 signaling. Nature Communications. 8 , 1-15. [More Information]
  • Read, S., O'Connor, K., Suppiah, V., Ahlenstiel, C., Obeid, S., Cook, K., Cunningham, A., Douglas, M., Hogg, P., Booth, D., George, J., Ahlenstiel, G. (2017). Zinc is a potent and specific inhibitor of IFN-/\3 signaling. Nature Communications. 8 , 1-15. [More Information]
  • Read, S., O'Connor, K., Suppiah, V., Ahlenstiel, C., Obeid, S., Cook, K., Cunningham, A., Douglas, M., Hogg, P., Booth, D., George, J., Ahlenstiel, G. (2017). Zinc is a potent and specific inhibitor of IFNL3 signaling. Nature Communications. 8 , 1-15. [More Information]
  • Read, S., O'Connor, K., Suppiah, V., Ahlenstiel, C., Obeid, S., Cook, K., Cunningham, A., Douglas, M., Hogg, P., Booth, D., George, J., Ahlenstiel, G. (2017). Zinc is a potent and specific inhibitor of IFNL3 signaling. Nature Communications. 8 , 1-15. [More Information]

2016
  • Ahlenstiel, G. (2016). Commentary. Gastroenterology Research Review. 33 , 1-5.
  • Ahlenstiel, G. (2016). Commentary. Gastroenterology Research Review. 34 , 1-4.
  • Ahlenstiel, G. (2016). Commentary. Gastroenterology Research Review. 30 , 1-4.

    Show 9 more
  • Ahlenstiel, G. (2016). Commentary. Gastroenterology Research Review. 39 , 1-4.
  • Ahlenstiel, G. (2016). Commentary. Gastroenterology Research Review. 37 , 1-5.
  • Ahlenstiel, G. (2016). Commentary. Gastroenterology Research Review. (31) , 1-5.
  • Ahlenstiel, G. (2016). Commentary. Gastroenterology Research Review. 38 , 1-4.
  • Ahlenstiel, G. (2016). Commentary. Gastroenterology Research Review. 32 , 1-4.
  • Ahlenstiel, G. (2016). Commentary. Gastroenterology Research Review. 36 , 1-5.
  • Eslam, M., Hashem, A., Romero-Gomez, M., Berg, T., Dore, G., Mangia, A., Chan, H., Irving, W., Sheridan, D., Abate, M., Weltman, M., Kelaeng, K., Ahlenstiel, G., Liddle, C., Douglas, M., Booth, D., George, J., et al (2016). FibroGENE: A gene-based model for staging liver fibrosis. Journal of Hepatology. 64 (2) , 390-398. [More Information]
  • O'Connor, K., Read, S., Wang, M., Schibeci, S., Eslam, M., Ong, A., Weltman, M., Douglas, M., Mazzola, A., Craxi, A., Stewart, G., Liddle, C., George, J., Ahlenstiel, G., Booth, D., et al (2016). IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infection. Genes and Immunity. 17 (6) , 328-334. [More Information]
  • Klein, A., Gizbar, M., Bourke, M., Ahlenstiel, G. (2016). Validated computed cleansing score for video capsule endoscopy. Digestive Endoscopy. 28 (5) , 564-569. [More Information]

2015
  • Ahlenstiel, G. (2015). Commentary. Gastroenterology Research Review. 21 , 1-4.
  • Ahlenstiel, G. (2015). Commentary. Gastroenterology Research Review. 22 , 1-4.
  • Ahlenstiel, G. (2015). Commentary. Gastroenterology Research Review. 23 , 1-5.

    Show 7 more
  • Ahlenstiel, G. (2015). Commentary. Gastroenterology Research Review. 24 , 1-4.
  • Ahlenstiel, G. (2015). Commentary. Gastroenterology Research Review. 25 , 1-4.
  • Ahlenstiel, G. (2015). Commentary. Gastroenterology Research Review. 26 , 1-4.
  • Musumba, C., Hsu, J., Ahlenstiel, G., Tutticci, N., Nanda, K., van der Poorten, D., Lee, E., Kwan, V. (2015). Feasibility and Safety of Overtubes for PEG-Tube Placement in Patients with Head and Neck Cancer. Gastroenterology Research and Practice. 2015 , 1-7. [More Information]
  • Eslam, M., Hashem, A., Leung, R., Romero-Gomez, M., Berg, T., Dore, G., Chan, H., Irving, W., Sheridan, D., Abate, M., Weltman, M., Douglas, M., Liddle, C., Booth, D., George, J., Ahlenstiel, G., et al (2015). Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease. Nature Communications. 6 , 1-10. [More Information]
  • Garcia, M., Ahlenstiel, G., Mahajan, H., van der Poorten, D. (2015). Small bowel varices secondary to chronic superior mesenteric vein thrombosis in a patient with heterozygous Factor V Leiden mutation: a case report. Journal of Medical Case Reports. 9 (1) , 1-4. [More Information]
  • Dold, L., Ahlenstiel, G., Eva, A., Luda, C., Schwarze-Zander, C., Boesecke, C., Wasmuth, J., Rockstroh, J., Spengler, U. (2015). Survival and HLA-B*57 in HIV/HCV co-infected patients on highly active antiretroviral therapy (HAART). PloS One. 10 (8) , 1-13. [More Information]

2014
  • Beard, M., Ffrench, R., Gowans, E., Helbig, K., Eyre, N., Douglas, M., Grebely, J., Ahlenstiel, G., Locarnini, S., George, J., et al (2014). A Summary of the 20(th) International Symposium on Hepatitis C Virus and Related Viruses. Gastroenterology. 147 (1) , e1-e4. [More Information]
  • Ahlenstiel, G., Hourigan, L., Brown, G., Zanati, S., Williams, S., Singh, R., Moss, A., Sonson, R., Bourke, M. (2014). Actual endoscopic versus predicted surgical mortality for treatment of advanced mucosal neoplasia of the colon. Gastrointestinal Endoscopy. 80 (4) , 668-676. [More Information]
  • O’Day, R., Ahlenstiel, G., Chittaranjan Shetty, A., Favaloro, E., Williams, S., Koutts, J. (2014). Artefactual "in-vitro coagulopathy" in a patient with non-Hodgkin lymphoma and lower gastrointestinal bleeding. Medical Journal of Australia. 200 (5) , 293-294. [More Information]

    Show 5 more
  • O'Connor, K., George, J., Booth, D., Ahlenstiel, G. (2014). Dendritic cells in hepatitis C virus infection: Key players in the IFNL3-genotype response. World Journal of Gastroenterology. 20 (47) , 17830-17838. [More Information]
  • Rotman, Y., Noureddin, M., Feld, J., Guedj, J., Witthaus, M., Han, H., Park, Y., Park, S., Heller, T., Ghany, M., Ahlenstiel, G., et al (2014). Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C. Gut (English Edition): an international journal of gastroenterology and hepatology. 63 (1) , 161-169. [More Information]
  • O'Connor, K., Parnell, G., Patrick, E., Ahlenstiel, G., Suppiah, V., van der Poorten, D., Read, S., Leung, R., Douglas, M., Yang, J., Stewart, G., Liddle, C., George, J., Booth, D. (2014). Hepatic metallothionein expression in chronic hepatitis C virus infection is IFNL3 genotype-dependent. Genes and Immunity. 15 (2) , 88-94. [More Information]
  • O'Connor, K., Ahlenstiel, G., Suppiah, V., Schibeci, S., Ong, A., Leung, R., van der Poorten, D., Douglas, M., Weltman, M., Stewart, G., Liddle, C., George, J., Booth, D. (2014). IFNL3 mediates interaction between innate immune cells: Implications for hepatitis C virus pathogenesis. Innate Immunity. 20 (6) , 598-605. [More Information]
  • Eslam, M., Leung, R., Romero-Gomez, M., Mangia, A., Irving, W., Sheridan, D., Spengler, U., Mollison, L., Cheng, W., Bugianesi, E., Douglas, M., Booth, D., George, J., Ahlenstiel, G., et al (2014). IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection. Journal of Hepatology. 61 (2) , 235-241. [More Information]

2013
  • Suppiah, V., Armstrong, N., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Dore, G., Irving, W., Stewart, G., George, J., Booth, D., Ahlenstiel, G., et al (2013). CCR5-Delta32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection. Genes and Immunity. 14 (5) , 286-290. [More Information]
  • Ahlenstiel, G., Sonson, R., Bourke, M. (2013). Diagnosis and treatment of radiation proctitis. Video Journal and Encyclopedia of GI Endoscopy. 1 (2) , 316-317. [More Information]
  • Eslam, M., Booth, D., George, J., Ahlenstiel, G. (2013). Interaction of IFNL3 with insulin resistance, steatosis and lipid metabolism in chronic hepatitis C virus infection. World Journal of Gastroenterology. 19 (41) , 7055-7061. [More Information]

    Show 2 more
  • O'Day, R., Gillies, M., Ahlenstiel, G. (2013). Ophthalmologic complications of antiviral therapy in hepatitis C treatment. World Journal of Gastroenterology. 19 (45) , 8227-8237. [More Information]
  • Ahlenstiel, G. (2013). The Natural Killer Cell Response to HCV Infection. Immune Network. 13 (5) , 168-176. [More Information]

2012
  • Edlich, B., Ahlenstiel, G., Azpiroz, A., Stoltzfus, J., Noureddin, M., Serti, E., Feld, J., Liang, T., Rotman, Y., Rehermann, B. (2012). Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients. Hepatology (Baltimore Md.). 55 (1) , 39-48. [More Information]
  • Edlich, B., Ahlenstiel, G., Azpiroz, A., Stoltzfus, J., Noureddin, M., Serti, E., Feld, J., Liang, T., Rotman, Y., Rehermann, B. (2012). Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients.. Hepatology (Baltimore Md.). 55 (1) , 39-48. [More Information]
  • Booth, D., Ahlenstiel, G., George, J. (2012). Pharmacogenomics of hepatitis C infections: personalizing therapy. Genome Medicine. 4 (12) , 1-10. [More Information]

    Show 1 more
  • Ahlenstiel, G., Booth, D., George, J. (2012). Will IL28B polymorphisms remain relevant to direct-acting antiviral treatment paradigms?. Antiviral Therapy. 17 (6 Pt B) , 1163-1170. [More Information]

2011
  • Ahlenstiel, G., Booth, D., George, J. (2011). Clinical significance of IL28B gene variation in hepatitis C virus infection. Hot Topics in viral Hepatitis. (20) , 17-24. [More Information]
  • Ahlenstiel, G., Edlich, B., Hogdal, L., Rotman, Y., Noureddin, M., Feld, J., Holz, L., Titerence, R., Liang, T., Rehermann, B. (2011). Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C. Gastroenterology. 141 (4) , 1231-1239. [More Information]
  • Smith, K., Suppiah, V., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Matthews, G., Irving, W., Ahlenstiel, G., Stewart, G., George, J., Booth, D., et al (2011). Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort. Genome Medicine. 3 (8) , 57-1-57-13. [More Information]

    Show 5 more
  • Suppiah, V., Gaudieri, S., Armstrong, N., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Dore, G., Ahlenstiel, G., Stewart, G., George, J., Booth, D., et al (2011). IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study. PLoS Medicine. 8 (9) , e1001092-1-e1001092-8. [More Information]
  • Suppiah, V., Gaudieri, S., Armstrong, N., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Dore, G., Ahlenstiel, G., Stewart, G., George, J., Booth, D., et al (2011). IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study. PLoS Medicine. 8 (9) , e1001092-1-e1001092-8. [More Information]
  • Suppiah, V., Gaudieri, S., Armstrong, N., O'Connor, K., Berg, T., Weltman, M., Abate, M., Spengler, U., Bassendine, M., Dore, G., Ahlenstiel, G., Stewart, G., George, J., Booth, D., et al (2011). IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study.. PLoS Medicine. 8 (9) , e1001092-1-e1001092-8. [More Information]
  • Feld, J., Modi, A., El-Diwany, R., Rotman, Y., Thomas, E., Ahlenstiel, G., Titerence, R., Koh, C., Cherepanov, V., Heller, T., et al (2011). S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders. Gastroenterology. 140 (3) , 830-839. [More Information]
  • Feld, J., Modi, A., El-Diwany, R., Rotman, Y., Thomas, E., Ahlenstiel, G., Titerence, R., Koh, C., Cherepanov, V., Heller, T., et al (2011). S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders.. Gastroenterology. 140 (3) , 830-839. [More Information]

2010
  • Ahlenstiel, G., Booth, D., George, J. (2010). IL28B in hepatitis C virus infection: translating pharmacogenomics into clinical practice. Journal of Gastroenterology and Hepatology. 45 (9) , 903-910. [More Information]
  • Ahlenstiel, G., Titerence, R., Koh, C., Edlich, B., Feld, J., Rotman, Y., Ghany, M., Hoofnagle, J., Liang, J., Heller, T., et al (2010). Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. Gastroenterology. 138 , 325-335. [More Information]
  • Ahlenstiel, G., Titerence, R., Koh, C., Edlich, B., Feld, J., Rotman, Y., Ghany, M., Hoofnagle, J., Liang, J., Heller, T., et al (2010). Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. Gastroenterology. 138 (1) , 325-335. [More Information]

    Show 1 more
  • Vogel, M., Ahlenstiel, G., Hintsche, B., Fenske, S., Trein, A., Lutz, T., Schurmann, D., Stephan, C., Khaykin, P., Bickel, M., et al (2010). The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive Individuals. European Journal of Medical Research. 15 (3) , 102-111.

2009
  • Ahlenstiel, G., Woitas, R., Iwan, A., Nattermann, J., Feldmann, G., Rockstroh, J., Oldenburg, J., Kupfer, B., Sauerbruch, T., Spengler, U. (2009). Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia. Immunological Investigations. 38 (3-4) , 284-296. [More Information]
  • Suppiah, V., Moldovan, M., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M., Bassendine, M., Spengler, U., Dore, G., Powell, E., Stewart, G., Booth, D., George, J., et al (2009). IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.. Nature Genetics. 41 (10) , 1100-1104. [More Information]
  • Mas Marques, A., Mueller, T., Welke, J., Taube, S., Sarrazin, C., Wiese, M., Halangk, J., Witt, H., Ahlenstiel, G., Spengler, U., et al (2009). Low-density lipoprotein receptor variants are associated with spontaneous and treatment-induced recovery from hepatitis C virus infection. Infection, Genetics and Evolution. 201 (5) , 27-36. [More Information]

    Show 1 more
  • Yoon, J., Shjiina, M., Ahlenstiel, G., Rehermann, B. (2009). Natural killer cell function is intact after direct exposure to infectious hepatitis C virions. Hepatology. 49 (1) , 12-21. [More Information]

2008
  • De Zorzi, M., Caggiari, L., Ahlenstiel, G., Rehermann, B., De Re, V. (2008). Description of two new major histocompatibility complex (MHC) class II DRB1 [Pan troglodytes (Patr)-DRB1] alleles.. Tissue Antigens: immune response genetics. 71 (5) , 490.
  • Ahlenstiel, G., Martin, M., Gao, X., Carrington, M., Rehermann, B. (2008). Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses. Journal of Clinical Investigation. 118 (3) , 1017-1026. [More Information]
  • Mix, H., Weller-Norman, C., Thimme, R., Ahlenstiel, G., Shin, E., Herkel, J., David, C., Lohse, A., Rehermann, B. (2008). Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis. Gastroenterology. 135 (6) , 2107-2118. [More Information]

    Show 2 more
  • Caggiari, L., De Zorzi, M., Ahlenstiel, G., Rehermann, B., De Re, V. (2008). Identification of new major histocompatibility complex-A, -B, -C alleles in chimpanzees (Pan troglodytes).. Tissue Antigens: immune response genetics. 72 (1) , 79-83. [More Information]
  • Nattermann, J., Vogel, M., Nischalke, H., Danta, M., Ahlenstiel, G., Michalk, M., Sauerbruch, T., Rockstroh, J., Spengler, U. (2008). The transforming growth factor-beta high-producer genotype is associated with response to hepatitis C virus-specific therapy in HIV-positive patients with acute hepatitis C. AIDS. 22 (11) , 1287-1292. [More Information]

2007
  • Ahlenstiel, G., Rehermann, B. (2007). Hepatic NK, NKT and T Cells. Liver Immunology - Principles and Practice. , 71-82.
  • Ahlenstiel, G., Roomp, K., Daumer, M., Nattermann, J., Vogel, M., Rockstroh, J., Beerenwinkel, N., Kaiser, R., Nischalke, H., Sauerbruch, T., et al (2007). Selective pressures of HLA genotypes and antiviral therapy on human immunodeficiency virus type 1 sequence mutation at a population level. Clinical and Vaccine Immunology. 14 (10) , 1266-1273. [More Information]
  • Ahlenstiel, G., Nischalke, H., Bueren, K., Berg, T., Vogel, M., Biermer, M., Grunhage, F., Sauerbruch, T., Rockstroh, J., Spengler, U., et al (2007). The GNB3 C825T polymorphism affects response to HCV therapy with pegylated interferon in HCV/HIV co-infected but not in HCV mono-infected patients. Journal of Hepatology. 47 (3) , 384-355. [More Information]

2006
  • Ahlenstiel, G., Feldmann, G., Nattermann, J., Nischalke, H., Gorschluter, M., Kuntzen, T., Gerhardt, T., Wolff, M., Sauerbruch, T., Spengler, U., et al (2006). Detection of human aspartyl (asparaginyl) beta-hydroxylase and homeobox B7 mRNA in brush cytology specimens from patients with bile duct cancer. Endoscopy. 38 (6) , 604-609. [More Information]
  • Vogel, M., Lichterfeld, M., Kaufmann, D., Mui, S., Altfeld, M., Voigt, E., Ahlenstiel, G., Kupfer, B., Walker, B., Spengler, U., et al (2006). Structured treatment interruptions following immediate initiation of HAART in eight patients with acute HIV-1 seroconversion. European Journal of Medical Research. 11 (7) , 273-278.
  • Nattermann, J., Ahlenstiel, G., Berg, T., Feldmann, G., Nischalke, H., Muller, T., Rockstroh, J., Woitas, R., Sauerbruch, T., Spengler, U. (2006). The tandem-repeat polymorphism of the DC-SIGNR gene in HCV infection. Journal of Viral Hepatitis. 13 (1) , 42-46. [More Information]

2005
  • Ahlenstiel, G., Rehermann, B. (2005). Hepatitis C Virus and the Threshold of Natural Killer Cell Inhibition. Hepatology. 41 (3) , 675-677. [More Information]